Items where Author is "O'Brien, J"
 | Up a level |
Article
Ouédraogo, G, Alexander-White, C, Bury, D, Clewell, HJ, Cronin, MTD, Cull, T, Dent, M, Desprez, B, Detroyer, A, Ellison, C, Giammanco, S, Hack, E, Hewitt, NJ, Kenna, G, Klaric, M, Kreiling, R, Lester, C, Mahony, C, Mombelli, E, Naciff, J , O'Brien, J, Schepky, A, Tozer, S, van der Burg, B, van Vugt, B, Stuard, S and Cosmetics Europe, (2022) Read-across and new approach methodologies applied in a 10-step framework for cosmetics safety assessment – A case study with parabens. Regulatory Toxicology and Pharmacology. ISSN 0273-2300
McLaughlin, G, Morris, N, Kavanagh, PV, Dowling, G, Power, JD, Twamley, B, O'Brien, J, Talbot, B, Sitte, HH and Brandt, SD (2016) Test purchase, synthesis and characterization of 3-fluorophenmetrazine (3-FPM) and differentiation from its ortho- and para-substituted isomers. Drug Testing and analysis. ISSN 1942-7611
Power, JD, Kavanagh, P, McLaughlin, G, Dowling, G, Barry, M, O'Brien, J, Talbot, B, Twamley, B and Brandt, SD (2016) Forensic analysis of P2P derived amphetamine synthesis impurities: identification and characterization of indene by-products. Drug Testing and Analysis. ISSN 1942-7611
McLaughlin, G, Morris, N, Kavanagh, PV, Power, JD, O'Brien, J, Talbot, B, Elliott, SP, Wallach, J, Hoang, K, Morrish, H and Brandt, SD (2016) Test purchase, synthesis, and characterization of 2-methoxydiphenidine (MXP) and differentiation from its meta- and para-substituted isomers. DRUG TESTING AND ANALYSIS, 8 (1). pp. 98-109. ISSN 1942-7603
Power, JD, Kavanagh, P, McLaughlin, G, O'Brien, J, Talbot, B, Barry, M, Twamley, B, Dowling, G and Brandt, SD (2015) Identification and characterization of an imidazolium by-product formed during the synthesis of 4-methylmethcathinone (mephedrone). DRUG TESTING AND ANALYSIS, 7 (10). pp. 894-902. ISSN 1942-7603
McLaughlin, G, Morris, N, Kavanagh, PV, Power, JD, Twamley, B, O'Brien, J, Talbot, B, Dowling, G and Brandt, SD (2015) The synthesis and characterization of the 'research chemical' N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide (3,5-AB-CHMFUPPYCA) and differentiation from its 5,3-regioisomer. Drug Testing and Analysis. ISSN 1942-7611